Immune Checkpoint Inhibitors in Melanoma of Unknown Primary

被引：0
|
作者：
Ho, F. [1 ]
Torphy, R. J. [1 ]
Tobin, R. P. [1 ]
Borgers, J. S. [2 ]
Vorwald, V. M. [1 ]
Amato, C. A. [3 ]
Van Gulick, R. [3 ]
Cogswell, D. T. [1 ]
Gonzalez, R. [3 ]
Lewis, K. D. [3 ]
Medina, T. M. [3 ]
Rioth, M. J. [3 ]
Gleisner, A. L. [1 ]
Robinson, W. A. [3 ]
McCarter, M. [1 ]
机构：
[1] Univ Colorado, Dept Surg, Aurora, CO USA
[2] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[3] Univ Colorado, Dept Med Oncol, Aurora, CO USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P166
引用
收藏
页码：S105 / S106
页数：2
相关论文
共 50 条
  • [21] Efficacy of immune checkpoint inhibitors in different types of melanoma
    Rossi, Ernesto
    Schinzari, Giovanni
    Maiorano, Brigida Anna
    Indellicati, Giulia
    Di Stefani, Alessandro
    Pagliara, Monica Maria
    Fragomeni, Simona Maria
    De Luca, Erika Valentina
    Sammarco, Maria Grazia
    Garganese, Giorgia
    Galli, Jacopo
    Blasi, Maria Antonietta
    Paludetti, Gaetano
    Scambia, Giovanni
    Peris, Ketty
    Tortora, Giampaolo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (01) : 4 - 13
  • [22] Immune Checkpoint Inhibitors in the Treatment of Metastatic Uveal Melanoma
    Kuo, J. C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 60 - 61
  • [23] Efficacy of immune checkpoint inhibitors for in-transit melanoma
    Nan Tie, Emilia
    Lai-Kwon, Julia
    Rtshiladze, Michael Alexander
    Na, Lumine
    Bozzi, James
    Read, Tavis
    Atkinson, Victoria
    Au-Yeung, George
    Long, Georgina
    McArthur, Grant A.
    Sandhu, Shahneen
    Saw, Robyn
    Walpole, Euan
    Menzies, Alexander
    Smithers, Mark
    Gyorki, David E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [24] Predictive biomarkers of response to immune checkpoint inhibitors in melanoma
    Nebhan, Caroline A.
    Johnson, Douglas B.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (02) : 137 - 145
  • [25] Assessment of immune checkpoint inhibitors expression in Uveal Melanoma
    Liang, Chen
    Tang, Lin Qiao
    Zhang, Jun Jun
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [26] Safety of immune checkpoint inhibitors in Chinese patients with melanoma
    Wen, Xizhi
    Wang, Yao
    Ding, Ya
    Li, Dandan
    Li, Jingjing
    Guo, Yiqun
    Peng, Ruiqing
    Zhao, Jingjing
    Zhang, Xing
    Zhang, Xiao-Shi
    MELANOMA RESEARCH, 2016, 26 (03) : 284 - 289
  • [27] Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma
    Fujimura, Taku
    Muto, Yusuke
    Asano, Yoshihide
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [28] Patients with Melanoma with unknown Primary Tumor show better Survival under Immune Checkpoint Inhibitor Therapy compared to Melanoma with known Primary Tumor
    Gedik, C.
    Chatzipantazi, M.
    Schroeter, U.
    Stockfleth, E.
    Gambichler, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 34 - 34
  • [29] Primary adrenal insufficiency with immune checkpoint inhibitors
    Reactions Weekly, 2020, 1805 (1) : 11 - 11
  • [30] Impact of immune checkpoint and BRAF inhibitors on the incidence of second primary malignancies (SPM) in melanoma.
    Budhathoki, Nibash
    Timilsina, Sunita
    Atluri, Prashanti
    Weber, Jeffrey S.
    Braunstein, Marc Justin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345